Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy
- 31 August 1995
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 130 (2) , 204-211
- https://doi.org/10.1016/0002-8703(95)90430-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The Neuropeptide Alpha-Melanocyte-Stimulating Hormone: A Key Component NeuroimmunomodulationNeuroimmunomodulation, 1994
- Elevated plasma interleukin-6 levels in patients with acute myocardial infarctionAmerican Heart Journal, 1993
- Modalities for reducing interleukin 1 activity in diseaseImmunology Today, 1993
- Proopiomelanocortin‐Derived Peptides and mRNA Are Expressed in Rat HeartAnnals of the New York Academy of Sciences, 1993
- Serum Tumor Necrosis Factor Levels in Acute Myocardial Infarction and Unstable Angina PectorisAngiology, 1993
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Circulating tumour necrosis factor‐α (cachectin) in myocardial infarctionJournal of Internal Medicine, 1989
- Neopterin as a marker for activated cell-mediated immunity: Application in HIV infectionImmunology Today, 1988
- Reduction of myocardial infarct size by neutrophil depletion: Effect of duration of occlusionAmerican Heart Journal, 1986
- Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.Circulation, 1983